BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31137883)

  • 1. Role of Mast Cell-Derived Adenosine in Cancer.
    Gorzalczany Y; Sagi-Eisenberg R
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cells are directly activated by contact with cancer cells by a mechanism involving autocrine formation of adenosine and autocrine/paracrine signaling of the adenosine A3 receptor.
    Gorzalczany Y; Akiva E; Klein O; Merimsky O; Sagi-Eisenberg R
    Cancer Lett; 2017 Jul; 397():23-32. PubMed ID: 28342985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cells: A double-edged sword in cancer.
    Derakhshani A; Vahidian F; Alihasanzadeh M; Mokhtarzadeh A; Lotfi Nezhad P; Baradaran B
    Immunol Lett; 2019 May; 209():28-35. PubMed ID: 30905824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast Cell-Tumor Interactions: Molecular Mechanisms of Recruitment, Intratumoral Communication and Potential Therapeutic Targets for Tumor Growth.
    Segura-Villalobos D; Ramírez-Moreno IG; Martínez-Aguilar M; Ibarra-Sánchez A; Muñoz-Bello JO; Anaya-Rubio I; Padilla A; Macías-Silva M; Lizano M; González-Espinosa C
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The critical role of mast cell-derived hypoxia-inducible factor-1α in regulating mast cell function.
    Liang X; Yin G; Ma Y; Xu K; Liu J; Li J
    J Pharm Pharmacol; 2016 Nov; 68(11):1409-1416. PubMed ID: 27671226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast Cells Are Directly Activated by Cancer Cell-Derived Extracellular Vesicles by a CD73- and Adenosine-Dependent Mechanism.
    Gorzalczany Y; Merimsky O; Sagi-Eisenberg R
    Transl Oncol; 2019 Dec; 12(12):1549-1556. PubMed ID: 31493676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine activates Gα
    Arizmendi N; Kulka M
    Biochem Pharmacol; 2018 Oct; 156():157-167. PubMed ID: 30099007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors.
    Feoktistov I; Ryzhov S; Goldstein AE; Biaggioni I
    Circ Res; 2003 Mar; 92(5):485-92. PubMed ID: 12600879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells.
    Feoktistov I; Goldstein AE; Biaggioni I
    Mol Pharmacol; 1999 Apr; 55(4):726-34. PubMed ID: 10101031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent regulatory roles of extracellular ATP in the degranulation response of mouse bone marrow-derived mast cells.
    Yoshida K; Ito M; Matsuoka I
    Int Immunopharmacol; 2017 Feb; 43():99-107. PubMed ID: 27988461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-4 amplifies the pro-inflammatory effect of adenosine in human mast cells by changing expression levels of adenosine receptors.
    Hua X; Chason KD; Patel JY; Naselsky WC; Tilley SL
    PLoS One; 2011; 6(9):e24947. PubMed ID: 21966389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity, inflammation and cancer: a leading role for adenosine.
    Antonioli L; Blandizzi C; Pacher P; Haskó G
    Nat Rev Cancer; 2013 Dec; 13(12):842-57. PubMed ID: 24226193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the adenosine signaling pathway in macrophages for cancer immunotherapy.
    Yang H; Zhang Z; Zhao K; Zhang Y; Yin X; Zhu G; Wang Z; Yan X; Li X; He T; Wang K
    Hum Immunol; 2024 May; 85(3):110774. PubMed ID: 38521664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine: roles of different receptor subtypes in mediating histamine release from human and rodent mast cells.
    Yip KH; Wong LL; Lau HY
    Inflamm Res; 2009 Apr; 58 Suppl 1():17-9. PubMed ID: 19271132
    [No Abstract]   [Full Text] [Related]  

  • 15. A glance at adenosine receptors: novel target for antitumor therapy.
    Merighi S; Mirandola P; Varani K; Gessi S; Leung E; Baraldi PG; Tabrizi MA; Borea PA
    Pharmacol Ther; 2003 Oct; 100(1):31-48. PubMed ID: 14550503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of mast cells by immunoglobulin E-receptor cross-linkage, but not through adenosine receptors, induces A1 expression and promotes survival.
    Möller C; Xiang Z; Nilsson G
    Clin Exp Allergy; 2003 Aug; 33(8):1135-40. PubMed ID: 12911789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanomas and mast cells: an ambiguous relationship.
    Kohl LM; Sumpter TL
    Melanoma Res; 2024 Feb; 34(1):1-8. PubMed ID: 37924526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine pathway and cancer: where do we go from here?
    Antonioli L; Haskó G; Fornai M; Colucci R; Blandizzi C
    Expert Opin Ther Targets; 2014 Sep; 18(9):973-7. PubMed ID: 24958495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast Cells Localize in Hypoxic Zones of Tumors and Secrete CCL-2 under Hypoxia through Activation of L-Type Calcium Channels.
    Ramírez-Moreno IG; Ibarra-Sánchez A; Castillo-Arellano JI; Blank U; González-Espinosa C
    J Immunol; 2020 Feb; 204(4):1056-1068. PubMed ID: 31900336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potency of pharmacological adenosine receptors agonist/antagonist on cancer cell apoptosis in tumor microenvironment, current status, and perspectives.
    Soleimani A; Bahreyni A; Roshan MK; Soltani A; Ryzhikov M; Shafiee M; Soukhtanloo M; Jaafari MR; Mashkani B; Hassanian SM
    J Cell Physiol; 2019 Mar; 234(3):2329-2336. PubMed ID: 30191994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.